Pemedolac
Pemedolac (AY-30715) is a potent analgesic with significant pain-relief efficacy against chemically induced and inflammatory pain in animal models. Pemedolac displays a notable separation between analgesic effects and anti-inflammatory activity, achieving effective pain relief at much lower doses than those required for anti-inflammatory or gastric irritant effects. Pemedolac also shows low ulcerogenic potential, indicating a safer profile compared to standard NSAIDs while being utilized for the treatment of neurological, skin, and musculoskeletal disorders.
Product Specifications
CAS Number
114716-16-4
Product Name Alternative
AY-30715
UNSPSC
12352005
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pemedolac.html
Smiles
OC(C[C@]1(C2=C([C@H](CO1)CC3=CC=CC=C3)C4=CC=CC=C4N2)CC)=O
Molecular Formula
C22H23NO3
Molecular Weight
349.42
References & Citations
[1]Pemedolac: a novel and long-acting non-narcotic analgesic
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mini Capsule Filter, PES,0.2μm, Low Bio, Sterile-R,300cm2,1/4"MultiStepHB @Sili.^NTP-M, None, Bag label
CD8 beta (Leu2 T lymphocyte antigen, MAL, OKT8 T Cell antigen, p32, T cell antigen Leu2, T cell surface glycoprotein CD8 beta, Suppressor/Cytotoxic T cell) (MaxLight 750) discontinued
LAMP1 (D2D11) XP® Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)